BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis

We retrospectively compared the outcomes and toxicities of melanoma brain metastases (MBM) patients treated with BRAF inhibitors (BRAFi) and stereotactic radiosurgery (SRS) with SRS alone. We identified 87 patients with 157 MBM treated with SRS alone from 2005 to 2013. Of these, 15 (17.2%) patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Melanoma Res
Main Authors: Patel, Kirtesh R., Chowdhary, Mudit, Switchenko, Jeffrey M., Kudchadkar, Ragini, Lawson, David H., Cassidy, Richard J., Prabhu, Roshan S., Khan, Mohammad K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4943024/
https://ncbi.nlm.nih.gov/pubmed/27223498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000268
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados